STOK (Stoke Therapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings

Stoke Therapeutics, Inc. Common Stock (STOK) is a publicly traded Healthcare sector company. As of May 20, 2026, STOK trades at $30.76 with a market cap of $1.81B and a P/E ratio of -10.54. STOK moved +1.13% today. Year to date, STOK is -6.93%; over the trailing twelve months it is +201.44%. Its 52-week range spans $5.35 to $40.22. Analyst consensus is strong buy with an average price target of $46.71. Rallies surfaces STOK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate STOK?

8 analysts cover STOK: 0 strong buy, 8 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $46.71.

STOK Key Metrics

Key financial metrics for STOK
MetricValue
Price$30.76
Market Cap$1.81B
P/E Ratio-10.54
EPS$-2.84
Dividend Yield0.00%
52-Week High$40.22
52-Week Low$5.35
Volume506.93K
Avg Volume0
Revenue (TTM)$32.08M
Net Income$-169.77M
Gross Margin0.00%

STOK Analyst Consensus

8 analysts cover STOK: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $46.71.

Recent STOK Insider Trades

  • Ticho Barry sold 2.24K (~$73.55K) on May 1, 2026.
  • Ticho Barry sold 1.84K (~$60.03K) on Apr 1, 2026.
  • Allan Jonathan sold 8.69K (~$292.36K) on Mar 20, 2026.

Common questions about STOK

What do analysts rate STOK?
8 analysts cover STOK: 0 strong buy, 8 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $46.71.
Does Rallies show STOK price targets?
Yes. Rallies tracks STOK analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is STOK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for STOK. It does not provide personalized investment advice.
STOK

STOK